(Q36496776)

English

Usefulness of omega-3 fatty acid supplementation in addition to mesalazine in maintaining remission in pediatric Crohn's disease: a double-blind, randomized, placebo-controlled study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 August 2017

Usefulness of omega-3 fatty acid supplementation in addition to mesalazine in maintaining remission in pediatric Crohn's disease: a double-blind, randomized, placebo-controlled study (English)

1 reference

Europe PubMed Central

14 August 2017

0 references

0 references

Crohn's disease

1 reference

based on heuristic

inferred from title

author name string

C Romano

1

1 reference

Europe PubMed Central

14 August 2017

S Cucchiara

2

1 reference

Europe PubMed Central

14 August 2017

A Barabino

3

1 reference

Europe PubMed Central

14 August 2017

V Annese

4

1 reference

Europe PubMed Central

14 August 2017

C Sferlazzas

5

1 reference

Europe PubMed Central

14 August 2017

language of work or name

0 references

publication date

1 December 2005

1 reference

Europe PubMed Central

14 August 2017

World Journal of Gastroenterology

1 reference

Europe PubMed Central

14 August 2017

11

1 reference

Europe PubMed Central

14 August 2017

45

1 reference

Europe PubMed Central

14 August 2017

7118-7121

1 reference

Europe PubMed Central

14 August 2017

Iatrogenic complications from chronic ear surgery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725070

30 September 2017

Safety and steroid-sparing experience using infliximab for Crohn's disease at a pediatric inflammatory bowel disease center

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725070

30 September 2017

Review article: a critical approach to new forms of treatment of Crohn's disease and ulcerative colitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725070

30 September 2017

Recent advances in inflammatory bowel disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725070

30 September 2017

Therapy of Crohn's disease in childhood.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725070

30 September 2017

Management of Crohn's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725070

30 September 2017

Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725070

30 September 2017

Inflammatory bowel disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725070

30 September 2017

Oxidants and free radicals in inflammatory bowel disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725070

30 September 2017

Long-term effects of dietary marine omega-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725070

30 September 2017

Leukotriene B5 is formed in human neutrophils after dietary supplementation with icosapentaenoic acid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725070

30 September 2017

Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725070

30 September 2017

Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial. Study Group Members (German Crohn's Disease Study Group).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725070

28 June 2018

Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725070

28 June 2018

Treatment of ulcerative colitis with fish oil n--3-omega-fatty acid: an open trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725070

28 June 2018

Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725070

21 September 2018

Immunomodulatory therapy for pediatric inflammatory bowel disease: changing patterns of use, 1990-2000.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725070

21 September 2018

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725070

21 September 2018

Azathioprine in paediatric inflammatory bowel disease: an Italian multicentre survey

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I45.7118

21 January 2018

Re: Triantafillidis et al.--Acute idiopathic pancreatitis complicating active Crohn's disease: favorable response to infliximab treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/16437657

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New targets for Crohn's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16437657

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Can fish oil maintain Crohn's disease in remission?

1 reference

https://pubmed.ncbi.nlm.nih.gov/16437657

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human absorption of fish oil fatty acids as triacylglycerols, free acids, or ethyl esters

1 reference

https://pubmed.ncbi.nlm.nih.gov/16437657

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antioxidant activity of 5-aminosalicylic acid against peroxidation of phosphatidylcholine liposomes in the presence of alpha-tocopherol: a synergistic interaction?

1 reference

https://pubmed.ncbi.nlm.nih.gov/16437657

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nutritional supplementation with N-3 fatty acids and antioxidants in patients with Crohn's disease in remission: effects on antioxidant status and fatty acid profile

1 reference

https://pubmed.ncbi.nlm.nih.gov/16437657

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Gastric lymphoma--an infectious disease?]

1 reference

https://pubmed.ncbi.nlm.nih.gov/16437657

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic potential of fish oil in the treatment of ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16437657

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Supplementation with n-3 fatty acids from fish oil in chronic inflammatory bowel disease--a randomized, placebo-controlled, double-blind cross-over trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/16437657

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fish-oil fatty acid supplementation in active rheumatoid arthritis. A double-blinded, controlled, crossover study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16437657

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3748/WJG.V11.I45.7118

1 reference

Europe PubMed Central

14 August 2017

1 reference

Europe PubMed Central

14 August 2017

1 reference

Europe PubMed Central

14 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36496776&oldid=1635459822"